Year archive

Abbisko Cayman Limited — 2023 filings

All 61 regulatory filings released by Abbisko Cayman Limited (2256) in 2023, sourced directly from the official regulator.

61 Filings

2023 Period

2023 filings (61)

Filing	Released	Lang
VOLUNTARY ANNOUNCEMENT - CSF-1R INHIBITOR PIMICOTINIB (ABSK021) GRANTED FAST TRACK DESIGNATION BY U.S. FDA Regulatory Filings	2023-12-14	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023 Regulatory Filings	2023-12-06	English
INSIDE INFORMATION - ABBISKO REACHED A LICENSE AGREEMENT WITH MERCK FOR PIMICOTINIB (ABSK021) Capital/Financing Update	2023-12-04	English
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN THE PHASE II CLINICAL TRIAL OF PIMICOTINIB (ABSK021) IN THE TREATMENT OF ADVANCED PANCREATIC CANCER IN CHINA Regulatory Filings	2023-11-27	English
VOLUNTARY ANNOUNCEMENT - CD73 INHIBITOR ABSK051 OBTAINED IND APPROVAL FROM NMPA Regulatory Filings	2023-11-08	English
VOLUNTARY ANNOUNCEMENT - FGFR4 MUTANT INHIBITOR ABSK012 OBTAINED CLINICAL STUDY APPROVAL FROM U.S. FDA Regulatory Filings	2023-11-07	English
VOLUNTARY ANNOUNCEMENT - CLINICAL UPDATES OF PIMICOTINIB (ABSK021) PRESENTED AT THE 2023 CTOS ANNUAL MEETING Regulatory Filings	2023-11-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023 Regulatory Filings	2023-11-01	English
VOLUNTARY ANNOUNCEMENT - TWO MAJOR CLINICAL UPDATES OF PIMICOTINIB (ABSK021) WILL BE PRESENTED AT THE 2023 CTOS ANNUAL MEETING Regulatory Filings	2023-10-30	English
VOLUNTARY ANNOUNCEMENT - IND APPROVAL BY NMPA OBTAINED FOR ABSK112 Regulatory Filings	2023-10-27	English
VOLUNTARY ANNOUNCEMENT - IMPORTANT CLINICAL RESEARCH RESULTS OF ABSK011 AND ABSK043 WILL PRESENT AT THE ESMO CONFERENCE Regulatory Filings	2023-10-16	English
VOLUNTARY ANNOUNCEMENT - PRECLINICAL STUDY RESULTS OF PRMT5*MTA AND PD-L1 PRESENT AT ENA Regulatory Filings	2023-10-16	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023 Share Issue/Capital Change	2023-10-09	English
VOLUNTARY ANNOUNCEMENT - ABSK011 HCC COMBO CLINICAL TRIAL APPROVED BY NMPA Regulatory Filings	2023-09-26	English
VOLUNTARY ANNOUNCEMENT - ABSK011 HCC CLINICAL TRIAL APPROVED BY U.S. FDA Regulatory Filings	2023-09-25	English
2023 INTERIM REPORT Interim / Quarterly Report	2023-09-18	English
VOLUNTARY ANNOUNCEMENT - ABSK021 PHASE III TGCT CLINICAL TRIAL APPROVED BY EMA Regulatory Filings	2023-09-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023 Regulatory Filings	2023-09-06	English
VOLUNTARY ANNOUNCEMENT - THE SHAREHOLDING OF THE FOUNDERS OF THE COMPANY Major Shareholding Notification	2023-08-29	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023 Interim / Quarterly Report	2023-08-15	English
DATE OF BOARD MEETING Regulatory Filings	2023-08-03	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023 Regulatory Filings	2023-08-03	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023 Major Shareholding Notification	2023-08-03	English
VOLUNTARY ANNOUNCEMENT - ABSK021 PHASE III TGCT TRIAL FIRST PATIENT DOSED IN US Regulatory Filings	2023-08-02	English
VOLUNTARY ANNOUNCEMENT - ABSK011 AND ABSK043 CLINICAL RESULTS WILL BE PRESENTED AT ESMO Regulatory Filings	2023-07-31	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023 Regulatory Filings	2023-07-06	English
VOLUNTARY ANNOUNCEMENT - EGFR EXON20INS INHIBITOR ABSK112 RECEIVED CLINICAL TRIAL APPROVAL FROM FDA Regulatory Filings	2023-07-04	English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS Board/Management Information	2023-06-19	English
RESIGNATION OF NON-EXECUTIVE DIRECTOR Board/Management Information	2023-06-19	English
NINTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Governance Information	2023-06-14	English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON JUNE 14, 2023 Declaration of Voting Results & Voting Rights Announcements	2023-06-14	English
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN PHASE II TRIAL OF CSF-1R INHIBITOR PIMICOTINIB FOR CGVHD Regulatory Filings	2023-06-12	English
VOLUNTARY ANNOUNCEMENT - CSF-1R INHIBITOR PIMICOTINIB GRANTED PRIME BY THE EMA Regulatory Filings	2023-06-07	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023 Regulatory Filings	2023-06-05	English
GRANT OF SHARE OPTIONS Share Issue/Capital Change	2023-06-01	English
VOLUNTARY ANNOUNCEMENT Regulatory Filings	2023-05-28	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023 Regulatory Filings	2023-05-05	English
VOLUNTARY ANNOUNCEMENT Regulatory Filings	2023-04-27	English
FORM OF PROXY FOR THE 2022 ANNUAL GENERAL MEETING Proxy Solicitation & Information Statement	2023-04-20	English
NOTICE OF THE ANNUAL GENERAL MEETING AGM Information	2023-04-20	English
PROPOSALS FOR GRANTING OF GENERAL MANDATES TO ISSUE SHARES AND TO REPURCHASE SHARES RE-ELECTION OF DIRECTORS RE-APPOINTMENT OF AUDITOR PROPOSED AMENDMENTS TO THE EIGHTH AMENDED AND RESTATED MEMORANDUM Proxy Solicitation & Information Statement	2023-04-20	English
2022 Environmental, Social and Governance Report Environmental & Social Information	2023-04-20	English
2022 Annual Report Annual Report	2023-04-20	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023 Regulatory Filings	2023-04-04	English
VOLUNTARY ANNOUNCEMENT Regulatory Filings	2023-04-03	English
GRANT OF SHARE OPTIONS Share Issue/Capital Change	2023-03-20	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023 Regulatory Filings	2023-03-20	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023 Regulatory Filings	2023-03-20	English
(Revised) Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022 Regulatory Filings	2023-03-20	English
VOLUNTARY ANNOUNCEMENT Regulatory Filings	2023-03-16	English
TERMS OF REFERENCE FOR THE REMUNERATION COMMITTEE Remuneration Information	2023-03-15	English
PROPOSED AMENDMENTS TO THE EIGHTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION AND THE ADOPTION OF THE NINTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION Governance Information	2023-03-15	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31, 2022 Annual Report	2023-03-15	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023 Share Issue/Capital Change	2023-03-03	English
DATE OF BOARD MEETING Regulatory Filings	2023-03-02	English
VOLUNTARY ANNOUNCEMENT Capital/Financing Update	2023-03-01	English
VOLUNTARY ANNOUNCEMENT Regulatory Filings	2023-02-22	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023 Share Issue/Capital Change	2023-02-03	English
VOLUNTARY ANNOUNCEMENT Regulatory Filings	2023-01-30	English
VOLUNTARY ANNOUNCEMENT Regulatory Filings	2023-01-16	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022 Major Shareholding Notification	2023-01-05	English